FreeQAs
 Request Exam  Contact
  • Home
  • View All Exams
  • New QA's
  • Upload
PRACTICE EXAMS:
  • Oracle
  • Fortinet
  • Juniper
  • Microsoft
  • Cisco
  • Citrix
  • CompTIA
  • VMware
  • ISC
  • SAP
  • EMC
  • PMI
  • HP
  • Salesforce
  • Other
  • Oracle
    Oracle
  • Fortinet
    Fortinet
  • Juniper
    Juniper
  • Microsoft
    Microsoft
  • Cisco
    Cisco
  • Citrix
    Citrix
  • CompTIA
    CompTIA
  • VMware
    VMware
  • ISC
    ISC
  • SAP
    SAP
  • EMC
    EMC
  • PMI
    PMI
  • HP
    HP
  • Salesforce
    Salesforce
  1. Home
  2. SCDM Certification
  3. CCDM Exam
  4. SCDM.CCDM.v2026-02-03.q51 Dumps
  • ««
  • «
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • »
Download Now

Question 46

Which of the following laboratory findings is a valid adverse event reported term that facilitates auto coding?

Correct Answer: A
When coding adverse events (AEs) using MedDRA (Medical Dictionary for Regulatory Activities), valid AE terms must correspond to specific, medically meaningful concepts that match directly to a Preferred Term (PT) or Lowest Level Term (LLT) in the dictionary.
Among the options, "Elevated HDL" (High-Density Lipoprotein) represents a single, medically interpretable, and standard term that can directly match to a MedDRA LLT or PT. This makes it suitable for auto-coding, where the system automatically maps verbatim terms to MedDRA entries without manual intervention.
In contrast:
ALT (B) and Abnormal SGOT (C) are incomplete or nonspecific; they describe test names or qualitative interpretations rather than events.
Option D lists multiple findings, making it too complex for automatic mapping. Such compound entries would require manual coding review.
According to GCDMP (Chapter: Medical Coding and Dictionaries), a valid AE term should be:
Clinically interpretable (not just a lab test name)
Unambiguous
Single-concept based, not a collection of results
Thus, option A (Elevated HDL) is correct, as it aligns with MedDRA's single-concept, standard terminology structure suitable for auto-coding.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Medical Coding and Dictionaries, Section 5.3 - Auto-coding and Verbatim Term Management ICH M1 MedDRA Term Selection: Points to Consider, Section 2.1 - Coding Principles ICH E2B(R3) - Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports
insert code

Question 47

Which information should be communicated by the Data Manager at regular intervals throughout a study?

Correct Answer: C
The Data Manager (DM) plays a critical role in maintaining transparent communication with the clinical study team regarding data quality and study progress. One of the most essential metrics regularly reported by the DM is the percentage of data entered and cleaned.
According to the Good Clinical Data Management Practices (GCDMP, Chapter: Communication and Study Reporting), these metrics provide insight into study status, data readiness for interim analysis, and timeline predictability for database lock. Regular communication includes:
Percent of CRFs entered and verified
Percent of queries resolved
Outstanding data issues or missing pages
Other options fall outside the Data Manager's direct responsibility:
A (Enrollment) is typically reported by clinical operations.
B (Staffing changes) are handled by site management.
D (Safety events) are communicated by the safety/pharmacovigilance team.
Thus, option C correctly reflects the Data Manager's responsibility for ongoing study communication.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Communication and Study Reporting, Section 5.3 - Study Metrics and Status Updates ICH E6(R2) GCP, Section 5.1.1 - Communication and Oversight in Quality Management FDA Guidance for Industry: Computerized Systems Used in Clinical Investigations, Section 6.5 - Data Status Reporting
insert code

Question 48

An astute monitor discovers that a site is using nebulized albuterol rather than the inhaler provided in the study screening kit for the albuterol challenge. Which is the best response from the Data Manager?

Correct Answer: D
In this scenario, the site has deviated from the approved study protocol by using a different formulation (nebulized albuterol instead of inhaler). This is considered a protocol deviation or violation, depending on study definitions.
Per GCDMP (Chapter: Data Validation and Cleaning) and ICH E6(R2), Data Managers are responsible for ensuring that all protocol deviations affecting data integrity or subject safety are accurately captured and documented within the clinical database. The appropriate action is to issue a data query prompting the site to record the deviation in the designated section (e.g., "Protocol Deviations" CRF).
Option A: Incorrect - it affects data comparability.
Option B: Escalation to the Ethics Committee is handled by the sponsor, not the Data Manager.
Option C: Updating the CRF guidelines is premature; first, the deviation must be logged and assessed.
Therefore, option D (Query the site to enter a Protocol Violation) is the correct and compliant action.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Data Validation and Cleaning, Section 6.2 - Query Management and Protocol Deviations ICH E6(R2) GCP, Section 4.5 - Compliance with Protocol FDA Guidance for Industry: Oversight of Clinical Investigations - Compliance and Protocol Deviation Reporting
insert code

Question 49

During an inspection to determine appropriate documentation for use of a computerized system, what SOP might the inspector expect to find?

Correct Answer: B
During a regulatory inspection, inspectors expect to find documented Standard Operating Procedures (SOPs) governing the use, validation, and maintenance of computerized systems, including data backup and recovery procedures.
According to the GCDMP (Chapter: Computerized Systems and Compliance) and FDA 21 CFR Part 11, organizations must maintain an SOP that ensures data protection against loss, corruption, or unauthorized access. The SOP should describe backup frequency, secure storage, verification of backup integrity, and procedures for data restoration.
While the Data Management Plan (A) and Edit Specifications (D) are study-level documents, and the Statistical Analysis Plan (C) focuses on analysis procedures, only a Data Backup Plan (B) constitutes a required system-level SOP ensuring compliance and data continuity.
Reference (CCDM-Verified Sources):
SCDM GCDMP, Chapter: Computerized Systems and Compliance, Section 5.2 - Data Security, Backup, and Recovery SOPs FDA 21 CFR Part 11 - Subpart B, Controls for Closed Systems ICH E6(R2) GCP, Section 5.5.3 - System Security, Data Backup, and Recovery Requirements
insert code

Question 50

An asthma study is taking into account local air quality and receives that data from the national weather bureau. Which information is needed to link research subject data to the air-quality readings?

Correct Answer: B
When integrating external environmental data such as air quality readings with clinical study data, it is essential to use location and time identifiers to properly align the environmental data with subject-level data.
According to the Good Clinical Data Management Practices (GCDMP, Chapter: Data Management Planning and Study Start-up), external data sources (like national weather or pollution databases) must be merged using common linkage variables that allow synchronization without breaching subject confidentiality. In this case:
Location identifiers (e.g., city, postal code, or region) align the subject's study site or residential area with the environmental dataset.
Time identifiers (e.g., date and time of data collection) ensure that the environmental readings correspond to the same period as the subject's clinical observations.
Including subject identifiers (option C or D) is unnecessary and would pose privacy and data protection risks. Instead, linkage is typically done at the aggregate (site or regional) level, maintaining compliance with HIPAA and GDPR.
Reference (CCDM-Verified Sources):
SCDM Good Clinical Data Management Practices (GCDMP), Chapter: Data Integration and External Data Handling, Section 4.3 - Linking External Data Sources ICH E6 (R2) GCP, Section 5.5.3 - Data Traceability and External Data Management FDA Guidance for Industry: Use of Electronic Health Record Data in Clinical Investigations, Section 5.2 - Linking and Integration Principles
insert code
  • ««
  • «
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • »
[×]

Download PDF File

Enter your email address to download SCDM.CCDM.v2026-02-03.q51 Dumps

Email:

FreeQAs

Our website provides the Largest and the most Latest vendors Certification Exam materials around the world.

Using dumps we provide to Pass the Exam, we has the Valid Dumps with passing guranteed just which you need.

  • DMCA
  • About
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
©2026 FreeQAs

www.freeqas.com materials do not contain actual questions and answers from Cisco's certification exams.